ATE431352T1 - Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen - Google Patents

Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen

Info

Publication number
ATE431352T1
ATE431352T1 AT01274809T AT01274809T ATE431352T1 AT E431352 T1 ATE431352 T1 AT E431352T1 AT 01274809 T AT01274809 T AT 01274809T AT 01274809 T AT01274809 T AT 01274809T AT E431352 T1 ATE431352 T1 AT E431352T1
Authority
AT
Austria
Prior art keywords
derivatives
carboplatin
present
pharmaceutical compositions
supermolecular
Prior art date
Application number
AT01274809T
Other languages
English (en)
Inventor
Jingzun Wang
Huisheng Qu
Lei Wang
Ting Wang
Original Assignee
Jingzun Wang
Huisheng Qu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jingzun Wang, Huisheng Qu filed Critical Jingzun Wang
Application granted granted Critical
Publication of ATE431352T1 publication Critical patent/ATE431352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01274809T 2001-11-30 2001-11-30 Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen ATE431352T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/001595 WO2003045962A1 (fr) 2001-11-30 2001-11-30 Derives de carboplatine supramoleculaires, leur preparation, compositions pharmaceutiques les contenant comme ingredient actif et utilisations de ces compositions

Publications (1)

Publication Number Publication Date
ATE431352T1 true ATE431352T1 (de) 2009-05-15

Family

ID=4574900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01274809T ATE431352T1 (de) 2001-11-30 2001-11-30 Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen

Country Status (8)

Country Link
US (1) US7259270B2 (de)
EP (1) EP1473298B1 (de)
JP (1) JP4235111B2 (de)
CN (1) CN100445293C (de)
AT (1) ATE431352T1 (de)
AU (1) AU2002221514A1 (de)
DE (1) DE60138739D1 (de)
WO (1) WO2003045962A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106132408B (zh) * 2015-04-10 2018-02-13 新纳特产品公司 一种双环铂的制备方法
JP6851989B2 (ja) * 2015-05-18 2021-03-31 シン−ナット プロダクツ エンタープライズ エルエルシー 医薬用共結晶及びその用途
KR20180018800A (ko) * 2015-06-19 2018-02-21 신-낫 프로덕츠 엔터프라이즈 엘엘씨 카보플라틴 계 공-결정의 약제학적 조성물 및 이의 용도
CA2988989A1 (en) 2015-06-19 2016-12-22 Syn-Nat Products Enterprise LLC Composition containing carboplatin and use
CN116854745A (zh) * 2015-06-25 2023-10-10 新纳特产品公司 药物共晶组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
CN1121380C (zh) * 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物

Also Published As

Publication number Publication date
CN100445293C (zh) 2008-12-24
AU2002221514A1 (en) 2003-06-10
JP4235111B2 (ja) 2009-03-11
US7259270B2 (en) 2007-08-21
WO2003045962A1 (fr) 2003-06-05
EP1473298B1 (de) 2009-05-13
CN1558909A (zh) 2004-12-29
EP1473298A1 (de) 2004-11-03
US20050165093A1 (en) 2005-07-28
EP1473298A4 (de) 2007-11-28
DE60138739D1 (de) 2009-06-25
JP2005515195A (ja) 2005-05-26

Similar Documents

Publication Publication Date Title
DE60108724D1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
CY1110395T1 (el) Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης
CY1108871T1 (el) Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
EE200000527A (et) Faktorit Xa pärssivad heterotsüklilised derivaadid
ES2094218T3 (es) Derivados de 2-nitroimidazol, su fabricacion, y agente radiosensibilizante que lo incluye como principio activo.
MX2022016263A (es) Derivados de ciclobutil-urea.
US5116949A (en) Benzoyl urea compound-albumin complex
DE602004020463D1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
NZ232929A (en) Tungsten compounds containing a lanthanide ion and their use in antiviral compositions
DE69923444D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
ES478605A1 (es) Un procedimiento para preparar derivados de flavano.
BG93114A (bg) Производни на бензонафтиридин-1,8 ,методи за получаването им и състави които ги съдържат
DE60138739D1 (de) Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen
ATE92036T1 (de) Kardiovaskulaer aktive verbindungen.
AR018198A1 (es) Soluciones estables de mitoxantrona, procedimiento para prepararlas, utilizacion de dichas soluciones para la preparacion de medicamentos y losmedicamentos de aplicacion de dichas soluciones para el tratamiento de enfermedades cancerosas
JPS6016933B2 (ja) ２，６−ジメチル−３，５−ジメトキシカルボニル−４−（０−ジフルオロメトキシフエニル）−１，４−ジヒドロピリジン
ES2059471T3 (es) Un procedimiento para preparar un derivado de rodamina.
KR870006043A (ko) 피라진유도체 그 제조방법 및 약제조성물
Kovacic et al. Anticancer quinones and quinolines: mode of action via electron transfer and oxidative stress
DE60119378T8 (de) Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten
BR0206311A (pt) Composto, composição farmacêutica, e, utilização de um composto
ATE57692T1 (de) Chemische verbindung mit antimykotischer, vernarbungsfoerdernder und entzuendungshemmender wirkung.
DE60124581D1 (de) Triazoloä4,5-düpyrimidinderivate als antithrombotische verbindungen
Field et al. Biologically oriented organic sulfur chemistry. II. Formation of hemimercaptals or hemimercaptoles (. alpha.-hydroxy sulfides) as a means of latentiating thiols

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties